Cytel software
Cytel LogXact - Exact Interference Software for Logistic Regression
The complexity of conducting regression analysis over multiple covariates is well-documented. The challenge only intensifies when coupled with small sample sizes or missing data sets. LogXact aims to provide simple and accurate solutions for such difficulties.
Cytel - Clinical Trial Strategy Platform
Solara® is the first-to-market clinical trial strategy platform for simulation-guided clinical study design and selection. Using Solara, product development team explore thousands of new and varied design options, carefully pressure-test designs across a range of potential scenarios, and quantify tradeoffs to manage uncertainty, minimize costs, and accelerate speed to market.
Cytel StatXact - Statistical and Predictive Software
StatXact 12 provides statisticians in disciplines across the social and natural sciences with the world’s most expansive toolkit for exact inference and power analysis. Offering more than 160 tests and procedures, the StatXact® suite has transformed the complex algorithms of modern statistical analysis into a validated software package with a user-friendly interface.
Cytel - Bayesian Clinical Trial Designs Software
East Bayes provides easy access to complex Bayesian designs for all users. Cytel is bringing you East Bayes as a web-based extension of East for clinical trial design that blends the pace of SaaS delivery, the ease of use and robustness of Cytel software, and the velocity of cloud-based computing.
Cytel - Access Control Execution System (ACES) Software
The use of independent Data Monitoring Committees (DMCs) for clinical trials has grown dramatically across all therapeutic areas. As such practice continues to expand, sponsors face increased pressure to form committees that ensure adherence to charters, study protocols and regulatory requirements. ACES provides support to DMCs by offering a web-based trial workflow and document management system. Trial sponsors use ACES to comply with regulatory guidance, and to communicate in a secure environment about interim data and recommendations made by the DMC/DSMB, Independent Statistical Center and the clinical team.